medigraphic.com
SPANISH

Revista Médica del Instituto Mexicano del Seguro Social

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 4

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2005; 43 (4)

Knowledge of Phytopharmaceuticals Among Physicians from Morelos, Mexico

Romero CO, Reyes MH, Torres TBI, Herrera AA, Tortoriello J
Full text How to cite this article

Language: Spanish
References: 10
Page: 281-286
PDF size: 79.09 Kb.


Key words:

Phytotherapy, plants medicinal, primary health care.

ABSTRACT

Objectives: To analyze the proportion of primary care physicians from the Health System in the State of Morelos with knowledge about phytopharmaceuticals, and to explore some factors related to this knowledge.
Material and methods: Through a descriptive, transversal and prospective study, physicians who work in the Instituto Mexicano del Seguro Social, in the Secretaría de Salud in the State of Morelos, and in private practice, an “adequate knowledge” was conveyed when 70 % or more answers were correct and “deficient knowledge”, when this proportion was lower than 70 %. A bivariated analysis was used in order to determine association and statistical differences.
Results: A total of 264 physicians were included. The majority (90.2 %) fell in the group of “deficient knowledge”, and only 9.8 % fell into the “adequate knowledge” group. An association was found between the possession of adequate knowledge and private physicians (PR = 4.66, IC = 95 %), as well as deficient knowledge and working in a morning shift (PR = 2.92, CI = 95 %).
Conclusions: As the results demonstrate, know-ledge about phytopharmaceuticals among primary care physicians is deficient, regardless of the institution where they work.


REFERENCES

  1. 1. Houghton PJ. The role of plants in traditional medicine and current therapy. J Altern Complement Med 1995; 1:131-143.

  2. 2. Organización Mundial de la Salud. Reporte. Promoción y desarrollo de la medicina tradicional. Conferencia internacional sobre atención primaria a la salud. Ginebra/Alma Ata URSS: OMS; 1978. p. 6-12.

  3. 3. Organización Mundial de la Salud. Guías para el ase-soramiento y la regulación de las medicinas tradicio-nales. Ginebra: OMS; 1992.

  4. 4. Alonso J. Aplicación de los fitofármacos en la clínica diaria. En: Lozoya X, editor. Los fitofármacos en la clínica mo-derna. México: IMSS-Farmasa Schwabe; 2001. p. 79-88.

  5. 5. García-González M, Cáceres A. Legislación en Ibero-américa sobre fitofármacos y productos naturales. Primera edición. Costa Rica: Universidad de Costa Rica; 2000. p. 21, 327-341.

  6. 6. King SR. Pharmaceutical discovery, ethnobotany, tropical forest, and reciprocity: integrating indigenous knowledge, conservation, and sustainable development. En: Plotkin M, Famolare L, editors. Sustainable harvest and marketing of rain forest products. Washington, DC: Island Press; 1992. p. 231-238.

  7. 7. Lozoya X. Función de las plantas medicinales en la medicina del siglo XXI. En: Kumate J, editor. La investigación científica en la herbolaria medicinal mexicana. México: Secretaría de Salud; 1993. p. 255.

  8. 8. Farnsworth NR. The role of ethnopharmacology in drug development. Ciba Found Symp 1990;154:2-11.

  9. 9. Rodríguez-Rivas M, López-Guerra R, Casas-Blanco JC. Fitofármacos en la atención primaria de la salud: disponibilidad y uso. Acta Farmacéutica Bonarence 2002;3:213-217.

  10. Romero-Cerecero O, Reyes-Morales H, Herrera-Arellano A, Lozoya- Legorreta X, Tortoriello J. Aceptación de los fitofármacos por médicos y pacientes en clínicas de atención primaria. Rev Med IMSS 2004;42:125-130.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Inst Mex Seguro Soc. 2005;43